Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: Insights on Ski-mediated repression of TGF-β signaling

Cell

Volumn 111, Issue 3, 2002, Pages 357-367

  Wu, Jia Wei ^a   Krawitz, Ariel R ^b   Chai, Jijie ^a   Li, Wenyu ^a   Zhang, Fangjiu ^b   Luo, Kunxin ^b   Shi, Yigong ^a  

^a PRINCETON UNIVERSITY   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN; ONCOPROTEIN; ONCOPROTEIN SKI; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ZINC;

ARTICLE; ATOM; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA BINDING; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 0036848069     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)01006-1     Document Type: Article

References (46)

1. Akiyoshi S., Inoue H., Hanai J., Kusanagi K., Nemoto N., Miyazono K., Kawabata M. c-Ski acts as a transcriptional co-repressor in transforming growth factor β signaling through interaction with Smads. J. Biol. Chem. 274:1999;35269-35277.
2. Bottomley M., Collard M.W., Huggenvik J.I., Liu Z., Gibson T.J., Sattler M. The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation. Nat. Struct. Biol. 8:2001;626-633.
3. Boyer P.L., Colmenares C., Stavnezer E., Hughes S.H. Sequence and biological activity of chicken snoN cDNA clones. Oncogene. 8:1993;457-466.
4. Brunger A.T., Adams P.D., Clore G.M., Delano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S.et al. Crystallography and NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D. 54:1998;905-921.
5. Chai J., Du C., Wu J.-W., Kyin S., Wang X., Shi Y. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature. 406:2000;855-862.
6. Colmenares C., Stavnezer E. The Ski oncogene induces muscle differentiation in quail embryo cells. Cell. 59:1989;293-303.
7. Colmenares C., Stavnezer E. Structure and activities of the ski oncogene. Semin. Cancer Biol. 1:1990;383-387.
8. Colmenares C., Sutrave P., Hughes S.H., Stavnezer E. Activation of the c-Ski oncogene by overexpression. J. Virol. 65:1991;4929-4935.
9. Denissova N.G., Pouponnot C., Long J., Liu F. Transforming growth factor β-inducible independent binding of SMAD to the Smad7 promoter. Proc. Natl. Acad. Sci. USA. 97:2000;6397-6402.
10. Feng X.-H., Zhang Y., Wu R.-Y., Derynck R. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation. Genes Dev. 12:1998;2153-2163.
11. Fumagalli S., Doneda L., Nomura N., Larizza L. Expression of the c-Ski proto-oncogene in human melanoma cell lines. Melanoma Res. 3:1993;23-27.
12. Heldin C.-H., Miyazomo K., ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471.
13. Holm L., Sander C. Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233:1993;123-138.
14. Janknecht R., Wells N.J., Hunter T. TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev. 12:1998;2114-2119.
15. Jones T.A., Zou J.-Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A47:1991;110-119.
16. Kielkopf C.L., Rodionova N.A., Green M.R., Burley S.K. A novel peptide recognition mode revealed by the X-ray structure of a core U2AF35/U2AF65 heterodimer. Cell. 106:2001;595-605.
17. Klaulis P.J. Molscript. a program to produce both detailed and schematic plots of protein structures J. Appl. Crystallogr. 24:1991;946-950.
18. Liu X., Sun Y., Weinberg R.A., Lodish H.F. Ski/Sno and TGF-β signaling. Cytokine Growth Factor Rev. 12:2001;1-8.
19. Luo K., Stroschein S.L., Wang W., Chen D., Martens E., Zhou S., Zhou Q. The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling. Genes Dev. 13:1999;2196-2206.
20. Massagué J. TGF-β signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
21. Massagué J., Chen Y.-G. Controlling TGF-β signaling. Genes Dev. 14:2000;627-644.
22. Massagué J., Blain S.W., Lo R.S. TGF-β signaling in growth control, cancer, and heritable disorders. Cell. 103:2000;295-309.
23. Miyazono K., ten Dijke P., Heldin C.H. TGF-β signaling by Smad proteins. Adv. Immunol. 75:2000;115-157.
24. Navaza J. AMoRe and automated package for molecular replacement. Acta Crystallogr. A50:1994;157-163.
25. Nicholls A., Sharp K.A., Honig B. Protein folding and association. insights from the interfacial and thermodynamic properties of hydrocarbons Proteins. 11:1991;281-296.
26. Nomura N., Sasamoto S., Ishii S., Date T., Matsui M., Ishizaki R. Isolation of human cDNA clones of Ski and the Ski-related gene, sno. Nucleic Acids Res. 17:1989;5489-5500.
27. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
28. Pouponnot C., Jayaraman L., Massagué J. Physical and functional interaction of SMADs and p300/CBP. J. Biol. Chem. 273:1998;22865-22868.
29. Qin B.Y., Lam S.S., Correia J.J., Lin K. Smad3 allostery links TGF-β receptor kinase activation to transcriptional control. Genes Dev. 16:2002;1950-1963.
30. Roberts A.B., Sporn M.B. The transforming growth factor-βs. Sporn M.B., Roberts A.B. Peptide Growth Factors and Their Receptors. 1990;Springer-Verlag, Heidelberg, Germany. 419-472.pp.
31. Sakashita E., Sakamoto H. Protein-RNA and protein-protein interactions of the Drosophila sex-lethal mediated by its RNA-binding domains. J. Biochem. (Tokyo). 120:1996;1028-1033.
32. Shi Y. Structural insights on Smad function in TGFβ signaling. Bioessays. 23:2001;223-232.
33. Shi Y., Hata A., Lo R.S., Massagué J., Pavletich N.P. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature. 388:1997;87-93.
34. Shi Y., Wang Y.-F., Jayaraman L., Yang H., Massagué J., Pavletich N.P. Crystal structure of a Smad MH1 domain bound to DNA. insights on DNA binding in TGF-β signaling Cell. 94:1998;585-594.
35. Stavnezer E., Barkas A.E., Brennan L.A., Brodeur D., Li Y. Transforming Sloan-Kettering viruses generated from the cloned v-ski oncogene by in vitro and in vivo recombination. J. Virol. 57:1986;1073-1083.
36. Stroschein S.L., Wang W., Zhou S., Zhou Q., Luo K. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science. 286:1999;771-774.
37. Sun Y., Liu X., Eaton E.N., Lane W.S., Lodish H.F., Weinberg R.A. Interaction of the Ski oncoprotein with Smad3 regulates TGF-β signaling. Mol. Cell. 4:1999;499-509. a.
38. Sun Y., Liu X., Ng-Eaton E., Lodish H.F., Weinberg R.A. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling. Proc. Natl. Acad. Sci. USA. 96:1999;12442-12447. b.
39. Tokitou F., Nomura T., Khan M.M., Kaul S.C., Wadhwa R., Yasukawa T., Kohno I., Ishii S. Viral Ski inhibits Retinoblastoma Protein (Rb)-mediated transcriptional repression in a dominant negative fashion. J. Biol. Chem. 274:1999;4485-4488.
40. Topper J.N., DiChiara M.R., Brown J.D., Williams A.J., Collins T., Gimbrone M.A. Jr. CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor β transcriptional responses in endothelial cells. Proc. Natl. Acad. Sci. USA. 95:1998;9506-9511.
41. Wang W., Mariani F.V., Harland R.M., Luo K. Ski represses bone morphogenetic protein signaling in Xenopus and mammalian cells. Proc. Natl. Acad. Sci. USA. 97:2000;14394-14399.
42. Wrana J.L., Attisano L. The Smad pathway. Cytokine Growth Factor Rev. 11:2000;5-13.
43. Wu J.-W., Hu M., Chai J., Seoane J., Huse M., Li C., Rigotti D.J., Kyin S., Muir T.W., Fairman R.et al. Crystal structure of a phosphorylated Smad2. recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-β signaling Mol. Cell. 8:2001;1277-1289.
44. Xu W., Angelis K., Danielpour D., Haddad M.M., Bischof O., Campisi J., Stavnezer E., Medrano E. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type β transforming growth factor. Proc. Natl. Acad. Sci. USA. 97:2000;5924-5929.
45. Zheng G., Teumer J., Colmenares C., Richmond C., Stavnezer E. Identification of a core functional and structural domain of the v-Ski oncoprotein responsible for both transformation and myogenesis. Oncogene. 15:1997;459-471.
46. Zhou Q., Chen D., Pierstorff E., Luo K. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17:1998;2196-2206.